Early-stage predictors for treatment responses in patients with active lupus nephritis.

Abstract:

OBJECTIVE:We analyzed data of lupus nephritis (LN) patients to find parameters that can predict remission. METHODS:Sixty-four LN patients who were diagnosed with class III, IV, V or V + III/IV by renal biopsy and were followed up for more than six months in our center were enrolled retrospectively. Receiver operating characteristic curves were used to test the predictive values of urinary protein-to-creatinine ratio (UPCR), serum albumin and complement C3 at the first, second and third months as predictors for remission at the sixth month. RESULTS:The patients' renal pathologies were class III (five cases), class IV (33 cases), class V (nine cases) and class V + III/IV (17 cases). All patients received standard immunosuppressive therapy. Forty-six (71.9%) patients (grouped as the remission group) achieved remission at the end of the sixth month, including 23 complete remissions and 23 partial remissions. The other 18 patients were grouped as the no-remission group. There were no significant differences in clinical data, proportion of immunosuppressive therapy or renal pathological characteristics between the remission group and no-remission group at baseline, except the serum urea nitrogen of the remission group was lower than in the no-remission group. The UPCR were significantly lower in the remission group than in the no-remission group at months 1, 2, 3 and 6, respectively, while the serum albumin was significantly higher in the remission group than in the no-remission group at months 3 and 6, respectively. There were no significant differences in serum creatinine between the remission group and no-remission group, except at month 1. The C3 levels were higher in the remission group than in the no-remission group at months 1, 2 and 3, respectively. The areas under the curve (AUC) of the change percentage of UPCR at month 3 and the serum albumin at month 3 were the most significant (AUC 0.778, p = 0.002; AUC 0.773, p = 0.001, respectively). The cutoff value of the change percentage of UPCR at month 3 was 59%. The cutoff value of serum albumin at month 3 was 32.9g/l. CONCLUSION:The change percentage of UPCR ≥59% and the serum albumin ≥32.9 g/l at the third month were valuable for predicting remission at the sixth month in LN. Because of the small-size and retrospective nature, this study needs to be validated.

journal_name

Lupus

journal_title

Lupus

authors

Liu G,Wang H,Le J,Lan L,Xu Y,Yang Y,Chen J,Han F

doi

10.1177/0961203319826703

subject

Has Abstract

pub_date

2019-03-01 00:00:00

pages

283-289

issue

3

eissn

0961-2033

issn

1477-0962

journal_volume

28

pub_type

杂志文章

相关文献

LUPUS文献大全
  • Vaccination, atherosclerosis and systemic lupus erythematosus.

    abstract::Atherosclerosis is an inflammatory disease, leading to the formation of pro-inflammatory and pro-oxidative lipids that generate an immune response. Several antigens have been shown to activate the immune response and affect the development of atherogenesis. Systemic lupus erythematosus is an autoimmune and inflammator...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309345725

    authors: Carvalho JF,Pereira RM,Shoenfeld Y

    更新日期:2009-11-01 00:00:00

  • Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies.

    abstract::Although many types of neurological disorders and events have been described in association with antiphospholipid antibodies (aPL) and the antiphospholipid syndrome (APS), only ischaemic stroke is reasonably well established and accepted as a diagnostic criterion for the syndrome. We propose to evaluate, classify and ...

    journal_title:Lupus

    pub_type: 共识发展会议,杂志文章,评审

    doi:10.1191/0961203303lu392oa

    authors: Chapman J,Rand JH,Brey RL,Levine SR,Blatt I,Khamashta MA,Shoenfeld Y

    更新日期:2003-01-01 00:00:00

  • Comparison of articular manifestations of mixed connective tissue disease and systemic lupus erythematosus on clinical examination and musculoskeletal ultrasound.

    abstract:BACKGROUND:Polyarthritis is common to both mixed connective tissue disease (MCTD) and systemic lupus erythematosus (SLE). Apart from being erosive and deforming in the former, we speculated that it was more common and the extent of joints involved would be higher in MCTD. METHODS:This was a cross-sectional study that ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203318804891

    authors: Gunashekar S,Prakash M,Minz RW,Sharma A,Sharma S,Dhir V

    更新日期:2018-11-01 00:00:00

  • Systemic lupus erythematosus in a multiethnic U.S. cohort (LUMINA) XXVII: factors predictive of a decline to low levels of disease activity.

    abstract::The objective of this study was to examine factors predictive of a decline to low levels of disease activity in a cohort of systemic lupus erythematosus (SLE) patients. Patients with SLE of Hispanic (from Texas or Puerto Rico), African-American or Caucasian ethnicity from a multiethnic cohort were included. A decline ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203306lu2256oa

    authors: Bertoli AM,Alarcón GS,McGwin G Jr,Fernández M,Bastian HM,Fessler BJ,Vilá LM,Reveille JD,LUMINA Study Group.

    更新日期:2006-01-01 00:00:00

  • Diabetes mellitus complicating systemic lupus erythematosus - analysis of the UCL lupus cohort and review of the literature.

    abstract::Systemic lupus erythematosus (SLE) often coexists with other diseases. Diabetes mellitus (DM) is an example and patients with overlap SLE-DM can present with clinical features common to both disorders. In this review, we describe the patients with overlap SLE-DM, focussing on the clinical features common to both disea...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203308091539

    authors: Cortes S,Chambers S,Jerónimo A,Isenberg D

    更新日期:2008-11-01 00:00:00

  • A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus.

    abstract:OBJECTIVE:To determine if dehydroepiandrosterone (DHEA) is beneficial in severe systemic lupus erythematosus (SLE). METHODS:A double-blinded, placebo-controlled, randomized clinical trial in 21 patients with severe and active SLE, manifestated primarily by nephritis, serositis or hematological abnormalities. In additi...

    journal_title:Lupus

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1191/096120399678847588

    authors: van Vollenhoven RF,Park JL,Genovese MC,West JP,McGuire JL

    更新日期:1999-01-01 00:00:00

  • Anti-endothelial cell antibodies in systemic autoimmune diseases: prevalence and clinical significance.

    abstract:OBJECTIVE:To investigate the prevalence and characteristics of anti-endothelial cell antibodies (AECA) in a large cohort of patients with several well defined systemic autoimmune diseases, in order to determine their relationship with the clinical and laboratory features of these diseases. METHODS:Clinical and laborat...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339700600608

    authors: Navarro M,Cervera R,Font J,Reverter JC,Monteagudo J,Escolar G,López-Soto A,Ordinas A,Ingelmo M

    更新日期:1997-01-01 00:00:00

  • Mannose-binding lectin serum levels in patients with systemic lupus erythematosus: association with thrombocytopaenia and seizure.

    abstract::The complement system contributes to the pathogenesis of systemic lupus erythematosus (SLE). Mannose-binding lectin (MBL) is a key molecule of the lectin pathway of complement and seems to be related to the clinical manifestations of this disease. We evaluated the serum levels of MBL and its relationship with disease ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317722846

    authors: Cieslinski JZ,Skare TL,Nisihara R,De Messias-Reason IJ,Utiyama SRR

    更新日期:2018-03-01 00:00:00

  • Revisiting the anticardiolipin test and its standardization.

    abstract::Although the importance of the anticardiolipin test in diagnosis of antiphospholipid syndrome (APS) is widely accepted, there remains much misunderstanding about the strengths and weaknesses of this assay. Several disorders result in formation of low levels of the antibody, hence the anticardiolipin test is not specif...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203302lu202cr

    authors: Harris EN,Pierangeli SS

    更新日期:2002-01-01 00:00:00

  • Spot urine protein/creatinine ratio is unreliable estimate of 24 h proteinuria in lupus nephritis when the histological scores of activity index are higher.

    abstract:OBJECTIVES:The aim of this study was to evaluate the correlation and agreement of spot urine protein/creatinine (P/C) ratio with 24 h proteinuria in patients with lupus nephritis (LN) under different scores of activity index (AI). METHODS:In total, 90 pairs of 24 h urine and spot urine samples from 90 patients with bi...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315570688

    authors: Zhang Q,Sun L,Jin L

    更新日期:2015-08-01 00:00:00

  • Invasive fungal infections in patients with systemic lupus erythematosus: experience from affiliated hospitals of Catholic University of Korea.

    abstract::The purpose of study was to determine the nature, outcomes and associated risk factors of invasive fungal infection (IFI) in patients with systemic lupus erythematosus (SLE), and compare the incidence of IFI in patients with rheumatoid arthritis (RA). A total of 1155 patients with SLE and 2004 patients with RA were re...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309103081

    authors: Kim HJ,Park YJ,Kim WU,Park SH,Cho CS

    更新日期:2009-06-01 00:00:00

  • Unilateral facial erythematous patch as the presenting sign of systemic lupus erythematosus.

    abstract::Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder that can have many cutaneous manifestations including malar rash, discoid rash or oral ulcer. Isolated unilateral involvement of face is uncommon in SLE. It lacks typical clinical features of LE, and may impose a diagnostic challenge for clinicians. H...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320957739

    authors: Ha DL,Lee GW,Shin K,Kim HS,Ko HC,Kim BS,Kim MB

    更新日期:2020-12-01 00:00:00

  • False-positive IgM for CMV in pregnant women with autoimmune disease: a novel prognostic factor for poor pregnancy outcome.

    abstract::Our aims were to assess the frequency of false-positive IgM antibodies for cytomegalovirus in pregnant women with autoimmune diseases and in healthy women (controls) and to determine their relationship with pregnancy outcome. Data from 133 pregnancies in 118 patients with autoimmune diseases and from 222 pregnancies i...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203310361350

    authors: De Carolis S,Santucci S,Botta A,Garofalo S,Martino C,Perrelli A,Salvi S,Degennaro V,de Belvis A,Ferrazzani S,Scambia G

    更新日期:2010-06-01 00:00:00

  • The effect of acute physical exercise on cytokine levels in patients with systemic lupus erythematosus.

    abstract:BACKGROUND:Acute exercise increases IL-6, IL-10 and TNF-α levels in healthy subjects. There is no study evaluating the effect of exercise on cytokines level in systemic lupus erythematosus (SLE) patients. OBJECTIVE:Our aim was to assess IL-10, IL-6 and TNF-α levels at baseline and after acute physical exercise in pati...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313508832

    authors: da Silva AE,dos Reis-Neto ET,da Silva NP,Sato EI

    更新日期:2013-12-01 00:00:00

  • The lupus impact tracker is responsive to changes in clinical activity measured by the systemic lupus erythematosus responder index.

    abstract::Objective The lupus impact tracker (LIT) is a 10-item patient reported outcome tool to measure the impact of systemic lupus erythematosus or its treatment on patients' daily lives. Herein, we describe the responsiveness of the LIT and LupusQoL to changes in disease activity, using the systemic lupus erythematosus resp...

    journal_title:Lupus

    pub_type: 杂志文章,多中心研究

    doi:10.1177/0961203316667494

    authors: Devilliers H,Bonithon-Kopp C,Jolly M

    更新日期:2017-04-01 00:00:00

  • Juvenile systemic lupus erythematosus in the Sultanate of Oman: clinical and immunological comparison between familial and non-familial cases.

    abstract::Consanguineous marriage is quite prevalent in the Sultanate of Oman, with up to 45% of marriages being consanguineous. The aim of this study was to determine demographic, clinical and serological characteristics between familial and non-familial cases of juvenile systemic lupus erythematosus (SLE) in a highly consangu...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203310383299

    authors: Abdwani R,Hira M,Al-Nabhani D,Al-Zakwani I

    更新日期:2011-03-01 00:00:00

  • Improving the prognosis of SLE without prescribing lupus drugs and the primary care paradox.

    abstract::The outcome, quality of life and prognosis of lupus patients can be enhanced with close follow up and coordination between the individual's primary care physician and rheumatologist. Rheumatologists usually do not act as primary care physicians and leave health care maintenance to practitioners who need to be reminded...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307086267

    authors: Wallace DJ

    更新日期:2008-02-01 00:00:00

  • Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases.

    abstract::We retrospectively analysed the prevalence and clinical features associated to anti-Ku antibodies in patients affected by different autoimmune diseases. Anti-Ku antibodies are detected in 147 sera out of 7239 anti-ENA positive sera (2%). They are found in 2% of patients with systemic sclerosis (SSc) (8 out of 379), 1....

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308089442

    authors: Cavazzana I,Ceribelli A,Quinzanini M,Scarsi M,Airò P,Cattaneo R,Franceschini F

    更新日期:2008-08-01 00:00:00

  • Aggravated capillary non-perfusion after intravitreal bevacizumab for macular edema secondary to systemic lupus erythematosus and anti-phospholipid syndrome.

    abstract::A 22-year-old female with history of systemic lupus erythematosus (SLE) was referred for evaluation of decreased visual acuity in her right eye. Her best-corrected visual acuity (BCVA) at the time of presentation was 20/160. Widespread cotton wool spots and macular edema were seen on biomicroscopy. Fluorescein angiogr...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203311422095

    authors: Jeon S,Lee WK

    更新日期:2012-03-01 00:00:00

  • Mortality and years of potential life loss in systemic lupus erythematosus: a population-based cohort study.

    abstract::Multiple sources were used to identify 325 systemic lupus erythematosus (SLE) patients within the city of Oslo during 1999-2009 who met ≥ 4 of the American College of Rheumatology (ACR) criteria. The survival, standard mortality rate (SMR), years of potential life loss before 60 years of age (YPLL60) and causes of dea...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314551083

    authors: Lerang K,Gilboe IM,Steinar Thelle D,Gran JT

    更新日期:2014-12-01 00:00:00

  • Autoantibodies to topoisomerase I in a patient with systemic lupus erythematosus without features of scleroderma.

    abstract::We report a woman with systemic lupus erythematosus (SLE) with diffuse proliferative glomerulonephritis and anti-dsDNA antibodies whose serum contained autoantibodies specific for the phosphorylated form of RNA polymerase II (RNAP IIO), Su and ribosomal P antigen, as well as anti-topoisomerase I antibodies, a marker f...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339500400414

    authors: Stojanov L,Satoh M,Dooley MA,Kuwana M,Jennette JC,Reeves WH

    更新日期:1995-08-01 00:00:00

  • Genetic selection pressure in TLR9 gene may enforce risk for SLE in Indian Tamils.

    abstract::Objectives Lupus is a classical systemic autoimmune disease with genetics as one of the well known causative factors for the disease pathogenesis. Toll-like receptors are the major pattern recognition receptors associated with innate immunity and also act as an interface with the adaptive immunity. Genetic polymorphis...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316659151

    authors: Yusuf JH,Kaliyaperumal D,Jayaraman M,Ramanathan G,Devaraju P

    更新日期:2017-03-01 00:00:00

  • The national incidence and clinical picture of SLE in children in Australia - a report from the Australian Paediatric Surveillance Unit.

    abstract:OBJECTIVES:The objectives of this paper are to prospectively determine the incidence of paediatric systemic lupus erythematosus (pSLE) in Australia as well as describe the demographics, clinical presentation and one-year outcome. STUDY DESIGN:Newly diagnosed cases of pSLE were ascertained prospectively from October 20...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314552118

    authors: Mackie FE,Kainer G,Adib N,Boros C,Elliott EJ,Fahy R,Munro J,Murray K,Rosenberg A,Wainstein B,Ziegler JB,Singh-Grewal D

    更新日期:2015-01-01 00:00:00

  • Antiphospholipid syndrome and the idiotypic network.

    abstract::To study whether monoclonal anticardiolipin antibodies (aCL), derived from patients with antiphospholipid syndrome (APS), have similar pathogenic potential, we have employed an experimental model of antiphospholipid syndrome. Monoclonal aCL were produced by the combined method of EBV transformation and somatic cell hy...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339500400307

    authors: Bakimer R,Blank M,Kosashvilli D,Ichikawa K,Khamashta MA,Hughes GR,Koike T,Shoenfeld Y

    更新日期:1995-06-01 00:00:00

  • Double-blind, randomized, placebo-controlled pilot study of leflunomide in systemic lupus erythematosus.

    abstract::Twelve systemic lupus erythematosus (SLE) patients with mild to moderate disease activity (SLEDAI of > or = 6 and on prednisolone < 0.5 mg/kg/day) were included in a prospective, randomized, double-blind, placebo-controlled pilot study for 24 weeks. Six were randomized to receive oral leflunomide and six received plac...

    journal_title:Lupus

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1191/0961203304lu1067sr

    authors: Tam LS,Li EK,Wong CK,Lam CW,Szeto CC

    更新日期:2004-01-01 00:00:00

  • Risk-attitude and patient treatment preferences.

    abstract::Women's treatment preferences for lupus nephritis vary widely even after adjusting for sociodemographic factors and disease severity. Attitude toward risk may partially explain interpatient variability in treatment preference. The objective of this study was to examine the association between 'risk-attitude' and patie...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu371oa

    authors: Fraenkel L,Bogardus ST Jr,Wittink DR

    更新日期:2003-01-01 00:00:00

  • Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves.

    abstract:OBJECTIVE:To examine the potential immunologic mechanism and involvement of antiphospholipid antibodies in the pathogenesis of heart valve lesions in patients with the antiphospholipid syndrome (APS). METHODS:Immunoperoxidase and immunofluorescence staining methods were used to evaluate 13 heart valve specimens derive...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339600500306

    authors: Ziporen L,Goldberg I,Arad M,Hojnik M,Ordi-Ros J,Afek A,Blank M,Sandbank Y,Vilardell-Tarres M,de Torres I,Weinberger A,Asherson RA,Kopolovic Y,Shoenfeld Y

    更新日期:1996-06-01 00:00:00

  • Neurologic manifestations of antiphospholipid syndrome.

    abstract::Neurological involvement in antiphospholipid antibody syndrome (APS) is common, and its occurrence increases morbidity and mortality. Patients may present variable neurological involvement, such as cerebrovascular disease, cognitive dysfunction, headache, seizures, movement disorders, multiple sclerosis-like syndrome,...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203318776110

    authors: Ricarte IF,Dutra LA,Abrantes FF,Toso FF,Barsottini OGP,Silva GS,de Souza AWS,Andrade D

    更新日期:2018-08-01 00:00:00

  • Chylous ascites and podocytopathy as the presentation of childhood lupus-an unusual occurrence.

    abstract::Systemic lupus erythematosus (SLE) is an autoimmune disorder that can affect virtually any organ. Chylous ascites as a presenting manifestation of SLE has been described in a handful of cases in adults. However, to the best of our knowledge this presentation has never been reported in the pediatric age group. Podocyto...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203318817831

    authors: Pilania RK,Jindal AK,Sandesh G,Vignesh P,Suri D,Nada R,Singh S

    更新日期:2019-02-01 00:00:00

  • Pulmonary arterial hypertension in SLE: what do we know?

    abstract::Pulmonary hypertension (PH) can occur at any time during the course of systemic lupus erythematosus (SLE), and can be independent of lupus disease activity in other systems. The pathogenesis of PH in SLE can be multifactorial, but pulmonary arterial hypertension (PAH) is the commonest cause of PH in SLE. The internati...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313505010

    authors: Prabu A,Gordon C

    更新日期:2013-10-01 00:00:00